Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Albiges, L.; Rini, B. I.; Haanen, Jbag; Motzer, R. J.; Kollmannsberger, C. K.; Negrier, S.; Nole, F.; Bedke, J.; Bilen, M. A.; Nathan, P.; Tomita, Y.; Huang, B.; Ching, K. A.; Chudnovsky, A.; Robbins, P. B.; di Pietro, A.; Thomaidou, D.; Choueiri, T. K. |
| Abstract Title: | Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz249.007 |
| Language: | English |
| ACCESSION: | WOS:000491295502335 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz249.007 |
| Notes: | Meeting Abstract: 908PD -- Appears on pages v359-v360 of the abstract book -- Source: Wos |
